drugset / Trial / NCT04381689
Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Infants
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to evaluate the safety and immunogenicity of IL-YANG Inactivated Split Influenza Vaccine (IL-YANG Quadrivalent Seasonal Influenza Vaccine) in healthy infants from 6 months to under 3 years of age(≥ 6 months and \< 3 years)
Timeline
- Start
- 2024-10-23
- Primary completion
- 2025-05-20
- Completion
- 2025-10-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluarix Tetra | Vaccine | 0.5 ml | — |
| Subject | IL-YANG Quadrivalent Seasonal Influenza Vaccine | Vaccine | 0.5 ml | — |
Indications
No indication recorded.